Clinical Trials
CyanVac Selects Exothera for the Development and GMP Mfg...
CyanVac LLC, a vaccine company, announced that they have selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), for the development and manufacturing...
Clinical Trials
Phase 3 Trial Shows REGEN-COV antibody Cocktail Reduced Hospitalization...
Regeneron Pharmaceuticals, Inc. announced positive topline results from the largest trial to date assessing a COVID-19 treatment in infected non-hospitalized patients (n=4,567). This definitive Phase...
Clinical Trials
BioAge Initiates Phase 2 Trial of BGE-175 to Treat...
BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, announced that it has commenced a Phase 2 clinical...
Clinical Trials
Accenture and Phesi urges pharmaceutical companies to make use...
Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, and Accenture, a global services and consulting company with leading capabilities in...
Clinical Trials
CureVac Expands CVnCoV COVID-19 Vaccine Candidate Clinical Trial Analyses...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced plans to expand and further...
Clinical Trials
Moderna starts Phase I study of new Covid-19 vaccine...
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the first participants have been dosed in the Phase 2/3 study,...
Clinical Trials
TrialScope Welcomes Alexion to Its Growing Clinical Trial Disclosure...
TrialScope, the global leader in clinical trial disclosure and transparency technology, recently added Alexion to its rapidly expanding roster of customers.
Alexion joins the ranks of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.